Gilad W. Vainer

Standardization of the Teratoma Assay for Analysis of Pluripotency of Human ES Cells and Biosafety of Their Differentiated Progeny

Michal Gropp, Vitali Shilo, Gilad W. Vainer et al. · PLoS ONE · 2012 · 120 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +17

Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors

Deborah T. Blumenthal, Michal Yalon, Gilad W. Vainer et al. · Journal of Neuro-Oncology · 2016 · 102 citations

Medicine, Neurology, Oncology +11

A Harmonization Study for the Use of 22C3 PD-L1 Immunohistochemical Staining on Ventana’s Platform

Tzahi Neuman, Michal London, Juliane Kania-Almog et al. · Journal of Thoracic Oncology · 2016 · 90 citations · Full text

Medicine, Molecular Biology, Pathology +12

Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe

Denis Horgan, Giuseppe Curigliano, Olaf Rieß et al. · Journal of Personalized Medicine · 2022 · 60 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Klotho suppresses colorectal cancer through modulation of the unfolded protein response

Tammi Rubinstein, Shiri Shahmoon, Ehud Zigmond et al. · Oncogene · 2018 · 55 citations

Life Sciences, Molecular Biology, Oncology +14